It is appropriate that the recently released American Society of Clinical Oncology/Surgical Society of Oncology genetic testing guidelines endorse germline testing for BRCA1 and BRCA2 in all newly diagnosed women with breast cancer who are younger than age of 65 years. This evidence concerns the gene BRCA1 and breast cancer.